Lung function loss, smoking, vitamin C intake, and polymorphisms of the glutamate-cysteine ligase genes

American Journal of Respiratory and Critical Care Medicine

Volumn 178, Issue 1, 2008, Pages 13-19

  Siedlinski, Mateusz ^a   Postma, Dirkje S ^a   Van Diemen, Cleo C ^a   Blokstra, Anneke ^b   Smit, Henriette A ^b   Boezen, H Marike ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; GCLC; GCLM; Oxidative stress; Polymorphism

Indexed keywords

ASCORBIC ACID; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE COURSE; FEMALE; FORCED EXPIRATORY VOLUME; GCLC GENE; GCLM GENE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LINEAR REGRESSION ANALYSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRINUCLEOTIDE REPEAT; VITAMIN INTAKE;

ADULT; AGED; ANTIOXIDANTS; ASCORBIC ACID; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE-CYSTEINE LIGASE; HUMANS; LUNG; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TRINUCLEOTIDE REPEATS;

EID: 46349088492     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200711-1749OC     Document Type: Article

References (31)

1. World Health Organization. World Health Reports 2002 and 2003 [Internet], [Accessed Sep 2007]. Available from: http://www.who.int/ whr/previous/en/index. html
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
3. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD 2006 [Internet]. [Accessed Sep 2007]. Available from: http://www.goldcopd.org
4. Nakayama T, Church DF, Pryor WA. Quantitative analysis of the hydrogen peroxide formed in aqueous cigarette tar extracts. Free Radic Biol Med 1989;7:9-15.
5. Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006;111:476-494.
6. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2: 50-60.
7. Grievink L, Smit HA, Ocke MC, van't Veer P, Kromhout D. Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN study. Thorax 1998;53:166-171.
8. McKeever TM, .Scrivener S, Broadfleld E. Jones Z, Britton J, Lewis SA. Prospective study of diet and decline in lung function in a general population. Am J Respir Crit Care Med 2002;165:1299-1303.
9. Tabak C, Arts IC, Smit HA, Heederik D, Kromhout D. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN study. Am J Respir Crit Care Med 2001; 164:61-64.
10. Rahman I, Biswas SK, Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006;533:222-239.
11. Kinnula VL. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 2005;60:693-700.
12. Tricon S, Willers S, Smit HA, Burney PG, Devereux G, Frew AJ, Halken S, Host A. Nelson M, Shaheen S, et al. Nutrition and allergic disease. Clin Exp Allergy Rev 2006;6:117-188.
13. Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987;63:152-157.
14. Tiitto LH, Peltoniemi MJ, Kaarteenaho-Wiik RL, Soini YM, Paakko PK, Sormunen RT, Kinnula VL. Cell-specific regulation of gamma-glutamvlcvsteine synthetase in human interstitial lung diseases. Hum Pathol 2004;35:832-839.
15. Koide S, Kugiyama K, Sugiyama S, Nakamura S, Fukushima H, Honda O, Yoshimura M, Ogawa H. Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. J Am Coll Cardiol 2003;41:539-545.
16. Nakamura S, Kugiyama K. Sugiyama S, Miyamoto S, Koide S, Fukushima H, Honda O, Yoshimura M, Ogawa H. Polymorphism in the 5′-flanking region of human glutamate-cysteme ligase modifier subunit gene is associated with myocardial infarction. Circulation 2002;105: 2968-2973.
17. Walsh AC, Feulner J A, Reilly A. Evidence for functionally significant polymorphism of human glutamate cysteine ligase catalytic subunit: association with glutathione levels and drug resistance in the National Cancer Institute tumor cell line panel. Toxicol Sci 2001;61:218-223.
18. Hu RC, Tan SX, Dai AG. The relationship between the polymorphism of glutamate cysteine ligase modulatory subunit gene and the susceptibility to chronic obstructive pulmonary disease [in Chinese]. Zhonghua Jie He He Hu Xi Za Zhi 2006;29:100-103.
19. Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P, Deppen P, Preisig M, Ruiz V, Steullet P, et al. Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence. Proc Natl Acad Sci USA 2007;104:16621-16626.
20. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Schouten JP, Boezen HM. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 2005;172:329-333.
21. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Nolte IM, Boezen HM. Decorin and TGF-betal polymorphisms and development of COPD in a general population. Respir Res 2006;7:89.
22. Imboden M, Downs SH, Senn O, Matyas G, Brandli O, Russi EW, Schindler C, Ackermann-Liebrich U, Berger W, Probst-Hensch NM. Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALD1A cohort study. Respir Res 2007; 8:2.
23. He JQ, Connett JE, Anthonisen NR, Pare PD, Sandford AJ. Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med 2004;170:388-394.
24. Cheng SL, Yu CJ, Chen CJ, Yang PC. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 2004; 23:818-824.
25. Harju T, Kaarteenaho-Wiik R, Soini Y, Sormunen R, Kinnula VL. Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers' lung. Am J Respir Crit Care Med 2002;166: 754-759.
26. Rahman I, van Schadewijk AA, Hiemstra PS. Stolk J, van Krieken JH, MacNee W, de Boer WI. Localization of gamma-glutamylcysteine synthetase messenger ma expression in lungs of smokers and patients with chronic obstructive pulmonary disease. Free Radic Biol Med 2000;28:920-925.
27. Soini Y, Napankangas U, Jarvinen K, Kaarteenaho-Wiik R, Paakko P, Kinnula VL. Expression of gamma-glutamyl cysteine synthetase in nonsmall cell lung carcinoma. Cancer 2001;92:2911-2919.
28. Pierrou S. Broberg P, O'Donnell RA, Pawlowski K, Virtala R, Lindqvist E, Richter A, Wilson SJ, Angco G, Moller S, et al. Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am .J Respir Crit Care Med 2007;175:577-586.
29. Hackett NR, Heguy A, Harvey BG, O'Connor TP, Luettich K, Flieder DB, Kaplan R, Crystal RG. Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Biol 2003;29:331-343.
30. McKone EF, Shao J, Frangolias DD, Keener CL, Shephard CA, Farm FM, Tonelli MR, Pare PD, Sandford AJ. Aitken ML. et al. Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease. Am J Respir Crit Care Med 2006;174:415-419.
31. Linster CL. Van SE. Vitamin C: biosynthesis, recycling and degradation in mammals. FEBS J 2007;274:1-22.